Literature DB >> 29723859

Upregulation of NOX2 and NOX4 Mediated by TGF-β Signaling Pathway Exacerbates Cerebral Ischemia/Reperfusion Oxidative Stress Injury.

Zheng Lou1, Ai-Ping Wang2, Xiao-Ming Duan3, Guo-Huang Hu3,4, Gui-Lin Song3,5, Mei-Ling Zuo3, Zhong-Bao Yang3,5.   

Abstract

BACKGROUND/AIMS: Ischemic stroke is still one of the leading debilitating diseases with high morbidity and mortality. NADPH oxidase (NOX)-derived reactive oxygen species (ROS) play an important role in cerebral ischemia/reperfusion (I/R) injury. However, the mechanism underlying the regulation of ROS generation is still not fully elucidated. This study aims to explore the role of transforming growth beta (TGF-β) signals in ROS generation.
METHODS: Sprague-Dawley rats were subjected to I/R injury, and PC-12 cells were challenged by hypoxia/reoxygenation (H/R) and/or treated with activin receptor-like kinase (ALK5) inhibitor Sb505124 or siRNA against ALK5. Brain damage was evaluated using neurological scoring, triphenyl tetrazolium chloride staining, hematoxylin and eosin staining, infarct volume measurement, TUNEL staining, and caspase-3 activity measurement. Expression of TGF-β and oxidative stress-related genes was analyzed by real-time polymerase chain reaction and Western blot; NOX activity and ROS level were measured using spectrophotometry and fluorescence microscopy, respectively.
RESULTS: I/R contributed to severe brain damage (impaired neurological function, brain infarction, tissue edema, apoptosis), TGF-β signaling activation (upregulation of ALK5, phosphorylation of SMAD2/3) and oxidative stress (upregulation of NOX2/4, rapid release of ROS [oxidative burst]). However, Sb505124 significantly reversed these alterations and protected rats against I/R injury. As in the animal results, H/R also contributed to TGF-β signaling activation and oxidative stress. Likewise, the inhibition of ALK5 or ALK5 knockdown significantly reversed these alterations in PC-12 cells. Other than ALK5 knockdown, ALK5 inhibition had no effect on the expression of ALK5 in PC-12 cells.
CONCLUSIONS: Our studies demonstrated that TGF-β signaling activation is involved in the regulation of NOX2/NOX4 expression and exacerbates cerebral I/R injury.
© 2018 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  ALK5; Cerebral ischemia/reperfusion injury; NOX2; NOX4; ROS; TGF-β signaling

Mesh:

Substances:

Year:  2018        PMID: 29723859     DOI: 10.1159/000489450

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  30 in total

1.  lncRNA PINK1-AS Aggravates Cerebral Ischemia/Reperfusion Oxidative Stress Injury through Regulating ATF2 by Sponging miR-203.

Authors:  Zhong-Bao Yang; Yu Xiang; Mei-Lin Zuo; Li Mao; Guo-Huang Hu; Gui-Lin Song; Md Sayed Ali Sheikh; Li-Ming Tan
Journal:  Oxid Med Cell Longev       Date:  2022-07-09       Impact factor: 7.310

2.  Ginsenoside Rg1 attenuates cerebral ischemia-reperfusion injury due to inhibition of NOX2-mediated calcium homeostasis dysregulation in mice.

Authors:  Yuli Han; Xuewang Li; Liu Yang; Duoduo Zhang; Lan Li; Xianan Dong; Yan Li; Sen Qun; Weizu Li
Journal:  J Ginseng Res       Date:  2021-08-10       Impact factor: 5.735

3.  NOX2-mediated reactive oxygen species are double-edged swords in focal cerebral ischemia in mice.

Authors:  Ye Yingze; Jian Zhihong; Jin Tong; Li Yina; Zeng Zhi; Zhang Xu; Xiong Xiaoxing; Gu Lijuan
Journal:  J Neuroinflammation       Date:  2022-07-14       Impact factor: 9.587

4.  Long Non-coding RNA RMST Worsens Ischemic Stroke via MicroRNA-221-3p/PIK3R1/TGF-β Signaling Pathway.

Authors:  Jie Li; Ning Wang; Huan Nie; Shan Wang; Tongtong Jiang; Xuehan Ma; Wenjuan Liu; Kuo Tian
Journal:  Mol Neurobiol       Date:  2022-02-25       Impact factor: 5.682

5.  MiR-539 Targets MMP-9 to Regulate the Permeability of Blood-Brain Barrier in Ischemia/Reperfusion Injury of Brain.

Authors:  Feng Fan; Jiao Yang; Yuanjie Xu; Sheng Guan
Journal:  Neurochem Res       Date:  2018-10-01       Impact factor: 3.996

6.  PMN-MDSC Frequency Discriminates Active Versus Latent Tuberculosis and Could Play a Role in Counteracting the Immune-Mediated Lung Damage in Active Disease.

Authors:  Germana Grassi; Valentina Vanini; Federica De Santis; Alessandra Romagnoli; Alessandra Aiello; Rita Casetti; Eleonora Cimini; Veronica Bordoni; Stefania Notari; Gilda Cuzzi; Silvia Mosti; Gina Gualano; Fabrizio Palmieri; Maurizio Fraziano; Delia Goletti; Chiara Agrati; Alessandra Sacchi
Journal:  Front Immunol       Date:  2021-04-26       Impact factor: 7.561

Review 7.  TAK1 signaling is a potential therapeutic target for pathological angiogenesis.

Authors:  Linxin Zhu; Suraj Lama; Jiang-Hui Wang; Guei-Sheung Liu; Leilei Tu; Gregory J Dusting
Journal:  Angiogenesis       Date:  2021-05-10       Impact factor: 10.658

Review 8.  Primary cilia and ciliary signaling pathways in aging and age-related brain disorders.

Authors:  Rong Ma; Naseer A Kutchy; Liang Chen; Douglas D Meigs; Guoku Hu
Journal:  Neurobiol Dis       Date:  2021-12-31       Impact factor: 7.046

9.  Ryanodine receptor remodeling in cardiomyopathy and muscular dystrophy caused by lamin A/C gene mutation.

Authors:  Haikel Dridi; Wei Wu; Steven R Reiken; Rachel M Ofer; Yang Liu; Qi Yuan; Leah Sittenfeld; Jared Kushner; Antoine Muchir; Howard J Worman; Andrew R Marks
Journal:  Hum Mol Genet       Date:  2021-02-25       Impact factor: 6.150

10.  Macrophages induce the expression of lncRNA ATB via the secretion of TGF-β to relieve ischemia-reperfusion injury in cardiomyocytes.

Authors:  Hong Lin; Wen-Sheng Xu; Xiong-Wei Liu; Zhi Wang; Jiao Yan; Tao Zhang
Journal:  Exp Ther Med       Date:  2021-06-29       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.